Foresite Capital Management III as of March 31, 2020
Portfolio Holdings for Foresite Capital Management III
Foresite Capital Management III holds 9 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Myokardia | 28.8 | $18M | 386k | 46.88 | |
| Epizyme | 17.6 | $11M | 714k | 15.51 | |
| Blueprint Medicines (BPMC) | 15.8 | $9.9M | 170k | 58.48 | |
| Natera (NTRA) | 9.9 | $6.2M | 209k | 29.86 | |
| Immunomedics | 8.6 | $5.4M | 400k | 13.48 | |
| Aerie Pharmaceuticals | 7.7 | $4.8M | 357k | 13.50 | |
| Acceleron Pharma | 6.0 | $3.8M | 42k | 89.86 | |
| Biohaven Pharmaceutical Holding | 3.4 | $2.1M | 62k | 34.03 | |
| Fibrogen (FGEN) | 2.2 | $1.4M | 40k | 34.75 |
